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ABSTRACT: Macrophage migration inhibitory factor (MIF) is a multifunctional protein and a major mediator
of innate immunity. Although X-ray crystallography revealed that MIF exists as a homotrimer, its
oligomerization state in ViVo and the factors governing its oligomerization and stability remain poorly
understood. The C-terminal region of MIF is highly conserved and participates in several intramolecular
interactions that suggest a role in modulating the stability and biochemical activity of MIF. To determine
the importance of these interactions, point mutations (A48P, L46A), insertions (P107) at the
monomer-monomer interfaces, and C-terminal deletion (∆110-114NSTFA and ∆105-114NVGWNNSTFA)
variants were designed and their structural properties, thermodynamic stability, oligomerization state,
catalytic activity and receptor binding were characterized using a battery of biophysical methods. The
C-terminal deletion mutants ∆C5 huMIF1-109 and ∆C10 huMIF1-104 were enzymatically inactive and
thermodynamically less stable than wild type MIF. Analytical ultracentrifugation studies demonstrate
that both C-terminal mutants sediment as trimers and exhibit similar binding to CD74 as the wild type
protein. Disrupting the conformation of the C-terminal region 105-114 and increasing its conformational
flexibility through the insertion of a proline residue at position 107 was sufficient to reproduce the structural,
biochemical and thermodynamic properties of the deletion mutants. P107 MIF forms an enzymatically
inactive trimer and exhibits reduced thermodynamic stability relative to the wild type protein. To provide
a rationale for the changes induced by these mutations at the molecular level, we also performed molecular
dynamics simulations on these mutants in comparison to the wild type MIF. Together, our studies
demonstrate that intersubunit interactions involving the C-terminal region 105-114, including a salt-
bridge interaction between Arg73 of one monomer and the carboxy terminus of a neighboring monomer,
play critical roles in modulating tertiary structure stabilization, enzymatic activity, and thermodynamic
stability of MIF, but not its oligomerization state and receptor binding properties. Our results suggest that
targeting the C-terminal region could provide new strategies for allosteric modulation of MIF enzymatic
activity and the development of novel inhibitors of MIF tautomerase activity.
Macrophage migration inhibitory factor (MIF1) is an
important proinflammatory and immunoregulatory protein
that has been implicated in the pathogenesis of several
inflammatory and autoimmune diseases including sepsis (1, 2),
rheumatoid arthritis (3, 4), cancer (5, 6), diabetes (7), and
multiple sclerosis (8). MIF also is expressed under physi-
ological conditions in a wide variety of tissues and cell types
including neurons (9, 10) and is secreted by the anterior
pituitary gland as a consequence of the systemic stress
response or in response to low concentrations of gluco-
corticoids (11, 12).
Although originally identified as a T cell cytokine that is
released after an immune or inflammatory activation and acts
to inhibit the random migration of macrophages (13, 14),
studies over the past two decades have shown that MIF
possesses cytokine, enzymatic, hormone, and chaperone-like
activities (15) and is involved in a wide range of cellular
processes, including transcriptional regulation of inflamma-
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tory gene products (16), cell cycle control (17, 18), modula-
tion of cell proliferation and differentiation (19), regulating
glucocorticoı¨d activity (20), inactivation of p53 tumor
suppressor factor (21) and signal transduction. However, the
molecular mechanisms and structural basis underlying each
of these functions remain poorly understood. Therefore,
better understanding of the structural activity relationship of
MIF is critical for elucidating the molecular basis underlying
many of its biochemical and biological activities as well as
its role in disease.
MIF is known to possess two enzymatic activities: it can
act both as a keto-enol tautomerase and a thiol-protein
oxidoreductase. As a tautomerase, MIF catalyzes the
keto-enol tautomerization of D-dopachrome (22) and phe-
nylpyruvate (or hydroxyphenylpyruvate) (23, 24). As a thiol-
protein oxidoreductase, MIF catalyzes the reduction of insulin
and 2-hydroxyethyldisulfide (HED) by glutathione (GSH)
and dihydrolipoamide (DHL) (25, 26). However, the physi-
ological relevance of the catalytic activities of MIF and their
role in regulating its various biological functions remain
controversial. Furthermore, the natural substrates of MIF are
yet to be identified.
X-ray crystallographic and NMR studies demonstrate that
MIF exists predominantly as a homotrimer with dimensions
of approximately 35 × 50 × 50 Å (27, 28). Each monomer
consists of 114 amino acid residues (MW ∼ 12.3 kDa) and
exists as an R/ structure composed of two antiparallel
R-helices packed against a four-stranded -sheet (Figure S1;
see Supporting Information). The subunits interact via
intersubunit -sheet contacts to form a symmetrical -barrel
trimer with a solvent exposed central channel. The C-terminal
region of MIF comprising residues 105-114 is involved in
several intersubunit interactions and has been proposed to
be critical for trimer formation and stability (29-31). X-ray
crystallographic studies of MIF bound to its unnatural
substrates revealed that the tautomerase active site is formed
at the monomer-monomer interfaces and involves amino
acid residues from both neighboring subunits, whereas the
oxidoreductase activity is modulated by CALC motif (Cys57-
Ala-Leu-Cys60) within the -strand 4 (Figure 1B) of each
monomer (24, 25, 32).
Despite the extensive knowledge about the structure of
the MIF trimer, very little is known about the molecular and
structural determinants that govern the oligomerization of
MIF and the role of quaternary structure in modulating its
functions in health and disease. Previous structure activity
studies focused mainly on using site-directed mutagenesis
to elucidate the role of the N and carboxy terminal residues
in modulating the enzymatic activity and immunologic
functions of MIF. Two prior studies suggested that deletion
of the last 5-10 C-terminal residues does not affect the
overall structural stability of MIF, but reduces its enzymatic
and macrophage activating properties (31). However, the
molecular and structural basis underlying the biochemical
and functional consequences of these mutations and their
effect on the oligomerization state of MIF remains unknown.
Motivated by our interest in elucidating the role of
quaternary structure in modulating the activity of MIF in
health and disease, we sought to understand the relative
importance/contribution of intersubunit interactions involving
the C-terminus and elucidate the relationship between the
conformational flexibility of this region and the catalytic
activity and trimer stability of MIF. Deletion and point
mutation variants were generated to determine the conse-
quences of attenuating these intersubunit interactions on the
secondary structure, tertiary structure, oligomerization state,
enzymatic activity, thermodynamic stability and receptor
binding properties of MIF in Vitro. Our findings provide new
insight into the role of the carboxy terminal residues
105-114 in modulating the structural flexibility of MIF and
FIGURE 1: Structure of wt huMIF trimer: (A) top view; (B) side view. The three monomers are represented as cartoons and are colored in
cyan, magenta and lime. (C) Side view of the trimer illustrating the relative positions of the catalytic site and the C-terminal strands 6 and
7. Structural data according to ref 24; pdb code 1GD0. (D) Primary structure homology of different MIF species; structural data according
to the pdb codes 1CA7 and 1GD0 (human MIF); 1MFF (mouse MIF); 1P1G (variant of human MIF); 2GDG (variant of mouse MIF); 1UIZ
(MIF from Xenopus laeVis); and 2OS5 (MIF from Ancylostoma ceylanicum). Figures were generated with VMD (Visualization Molecular
Dynamics) software (53).
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suggest novel strategies for selective targeting of MIF
biochemical and immunologic functions based on modulating
its conformational and/or oligomerization states.
MATERIALS AND METHODS
Materials. Polymerase chain reaction (PCR) and other
molecular biology reagents were purchased from Stratagene
unless stated otherwise. DNA mini and maxi prep reagents
were purchased from Qiagen and oligonucleotide primers
from Microsynth. Escherichia coli BL21 (DE3) cells, rabbit
monoclonal anti-huMIF and goat antirabbit ALEXA Fluor
680 were purchased from Invitrogen. Miscellaneous chemi-
cals were from Sigma-Aldrich Chemicals and were of the
highest grade commercially available. Isopropyl 1-thio--
D-galactopyranoside (IPTG) was purchased from Applichem.
15N-Ammonium chloride and 13C-glucose were purchased
from CIL (Cambridge Isotope Laboratories, Switzerland).
Site-Directed Mutagenesis of C-Terminal Truncated hu-
MIF. Wt huMIF was amplified from Jurkat H33HJ-JA1 T
cell DNA and cloned into the pET11b expression vector as
described previously (33). C-Terminal truncated huMIF, ∆C5
huMIF1-109 and ∆C10 huMIF1-104, A48P huMIF and P107
huMIF mutants were engineered by site directed mutagenesis
using mutagenesis kit from Stratagene. C-Terminal trunca-
tions were designed to have either the last five amino acids
(NSTFA) or the last ten amino acids (NVGWNNSTFA)
deleted. All mutants of huMIF were cloned from huMIF-
pETllb by DNA amplification. Polymerase chain reactions
(PCR) were performed in a Px2 Thermal Cycler (Catalys
AG, a Promega Company). Initial denaturation was for 30 s
at 95 °C followed by x cycles of 30 s at 95 °C, 1 min at 55
°C, and (1 min/Kb of plasmid length) at 68 °C using 2.5
units of Pfu Turbo DNA polymerase (Stratagene) (x ) 18
for C-truncated mutants and x ) 16 for A48P and P107
mutants). Primers designed were 5′ GTG GGC TGG AAC
TAA GAG CCG CAG G 3′ (sense), 5′ C CTG CGG CTC
TTA GTT CCA GCC CAC 3′ (antisense) for C5 huMIF1-109;
5′ CGA CAT GAA CGC GGC CTA AGA GCC GCA GG
3′ (sense) and 5′ CC TGC GGC TCT TAG GCC GCG TTC
ATG TCG 3′ (antisense) for ∆C10 huMIF1-104; and 5′ CGG
ACC AGC TCA TGC CGT TCG GCG GCT CC 3′ (sense)
and 5′ GG AGC CGC CGA ACG GCA TGA GCT GGT
CCG 3′ (antisense) for A48P huMIF; and 5′ GCG GCC AAT
GTG CCG GGC TGG AAC 3′ (sense) and 5′ GTT GTT
CCA GCC CGG CAC ATT GGC 3′ (antisense) for P107
huMIF. Mutants DNA sequences were confirmed by se-
quencing at Microsynth by using T7 primer (http://www.
microsynth.ch/).
Expression and Purification of Wt and Mutant huMIF.
HuMIF-containing pETllb plasmid DNA was used to trans-
form the E. coli BL21 (DE3). One liter of culture was grown
at 37 °C until the optical density at 600 nm reached 0.6-0.65
and induced with isopropyl 1-thio--D-galactopyranoside
(IPTG) to a final concentration of 1 mM. After 4 h at 37 °C,
bacteria were harvested and the cell pellets were frozen at
-20 °C until use. For protein purification, the bacterial pellets
(∼4.7 g for 1 L of culture) were thawed and resuspended in
24 mL of lysis buffer (Tris 50 mM, KCl 50 mM, MgAc 5
mM, sodium azide 0.1%, pH 8.5) and lyzed by sonication
(Sonics Vibra Cell) for 20 min, then harvested by centrifuga-
tion for 25 min at 10 000 rpm (4 °C). Supernatant containing
huMIF was recovered and sterile-filtered through a 22 µm
membrane filter. All proteins were purified using a two step
purification strategy using anion exchange and size exclusion
chromatography that have been optimized to yield highly
pure proteins (>95%). The supernatant was loaded onto a
Mono Q anion exchange column (HiPrep 16/10 Q FF) and
eluted using a linear NaCl gradient (0.15-1.00 M NaCl) in
25 mM Tris buffer (pH 7.6) using a fast protein liquid
chromatography system (FPLC, AKTA Explorer1 Amersham
Pharmacia Biotech). Wt and mutants huMIF elute with the
flow through fractions. MIF-containing fractions were pooled,
concentrated and injected onto a Superdex 75 16/60 size
exclusion chromatography column equilibrated with Tris-
buffered saline (25 mM Tris, 150 mM NaCl, pH 7.6). HuMIF
containing fractions were pooled and concentrated to the
desired concentrations and kept at 4 °C until use. All
experiments with the C-terminal truncated mutants were
performed after filtering through 0.22 µm filters and within
two weeks from purification.
For preparation of uniformly [15N]-labeled and 13C/15N-
double-labeled huMIF, samples were prepared by growing
the bacteria on M9 minimal containing 15N-ammonium
chloride (1 g/L) as the only nitrogen source, or 15N-
ammonium chloride and 13C-glucose in case of double
labeled samples, supplemented with minerals and cofactors
(34).
SDS-PAGE Analysis. SDS-PAGE was performed under
reducing conditions. Protein samples were mixed with one
volume of the SDS sample buffer. 15 % gels (54 cm2) were
employed, and a voltage of 180 V was applied. The gels
were stained with coomassie blue and/or silver staining
(SilverXpress Silver Staining Protocols, Invitrogen), accord-
ing to the manufacturer protocol.
NatiVe PAGE. Native PAGE analysis was performed with
the Phast system on polyacrylamide mini gels type PhastGel
High density (ref. 17-0679-01, GE Healthcare) using native
buffer strips (Pharmacia Biotech). The Phast gel was prerun
at 250 V and 15 °C for 10 V h. Samples (1 µL) were loaded
at 250 V for 1 V h and electrophoresis was carried out at
400 V, 15 °C for 1600 V h. The gel was then stained with
silver staining.
MIF Keto-Enol Tautomerase ActiVity. The keto-enol
tautomerase activity of MIF was determined by measuring
the rate of formation of enol form of D-dopachrome methyl
ester and phenylpyruvate as model catalytic substrates of
MIF. MIF tautomerase activity using the D-dopachrome
substrate was performed as described previously (22).
D-Dopachrome methyl ester was freshly prepared by reaction
of periodate (NaIO4) (8 mM) on L-3,4-dihydroxyphenylala-
nine methyl ester (4 mM) for 5 min at room temperature
and then placed directly on ice before use. MIF activity was
then determined at room temperature by adding different
concentrations of D-dopachrome methyl ester to a cuvette
containing 50 mM potassium phosphate buffer, pH 6.0, and
0.5 mM EDTA. After 30 s approximately, 25 nM MIF was
added to the cuvette and resulted in a decrease in absorbance
at 475 nm that was followed for 1 min using a spectropho-
tometer (CARY 100 Bio UV-visible spectrophotometer).
Data presented are the average of at least 3 measurements.
MIF tautomerase activity using the phenylpyruvate sub-
strate was performed as described previously (35). The
enolase reaction of phenylpyruvate was assessed at room
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temperature by monitoring the increase in absorbance at 300
nm using the same spectrophotometer as before. The reaction
mixture contained in reaction buffer (200 mM sodium
phosphate, pH 6.2) 0.9 M boric acid and different concentra-
tions of the substrate (ketone form of phenylpyruvate)
prepared freshly in reaction buffer. 25 nM huMIF was added,
and the reaction was followed for 10 min. Initial rate of
catalytic activity was calculated within the first 30 s of the
reaction. Data presented are the average of at least 3
measurements.
Probing the Conformational and Thermodynamic Stability
of MIF by Circular Dichroism and Fluorescence Spectros-
copy. The far-UV (195-250 nm) CD spectra of wt and
mutant huMIF in PBS 1X (137 mM NaCl, 10 mM phosphate,
2.7 mM KCl, pH 7.4) were recorded at RT using a 0.1 cm
quartz cell and Jasco J-815 CD spectrometer equipped with
a thermostatted cell holder. Data were acquired at a step size
of 0.2 nm, an averaging time of 0.5 s, a bandwidth of 0.5
nm, and an average of three scans recorded to generate the
data reported in units of ellipticity. Thermal denaturation
(TD) studies were performed by recording the mean molar
ellipticity at 218 nm for each protein (14 µM) in PBS 1X as
a function of the temperature (20-95 °C). The spectra
represent the average of at least 3 scans. Data were collected
using a temperature slope of 2 °C/min with data pitch of
0.2 °C and a bandwidth of 1 nm. Unfolding curves are
expressed as the percentage of unfolded protein relative to
native protein (i.e., the change in ellipticity at 218 nm) over
the increase in temperature. Guanidine hydrochloride (Gd-
nHCl) induced denaturation studies were performed by
recording the mean molar ellipticity per residue as a function
of wavelength (195-240 nm) and GdnHCl concentration.
The spectra represent the average of at least 3 scans
performed on the protein sample (14 µM) in PBS 1X buffer
at RT. Scans were collected at 0.2 nm intervals with a
bandwidth of 1 nm and a time constant of 0.5 s. Unfolding
curves are expressed as the percentage of unfolded protein
relative to native protein (i.e., the change in ellipticity at 218
nm) over GdnHCl concentration. All far-UV CD data were
smoothed using a Steinman function (Kaleidagraph software),
which reduced the noise without perturbing the appearance
of the data.
Guanidine hydrochloride induced denaturation studies
were also performed by monitoring changes in the fluores-
cence emission maximum of wt and C-truncated mutants as
a function of GdnHCl concentration. The spectra represent
the average of at least 3 scans performed on the protein
sample (3 µM wt huMIF and ∆C5 huMIF1-109; 5 µM ∆C10
huMIF1-104) in PBS 1X incubated overnight at RT with
different concentrations of GdnHCl. The wt huMIF and ∆C5
huMIF1-109 mutant were excited at 295 and 280 nm, whereas
an excitation wavelength of 280 nm only was used for the
∆C10 huMIF1-104 mutant, which lacks the only tryptophan
residue in wt huMIF (Trp108). Fluorescence emission was
acquired over a wavelength range of 290-450 nm using a
LS 55 Perkin-Elmer fluorescence spectrometer. Unfolding
curves are expressed as the percentage of unfolded protein
relative to native protein (i.e., the change in fluorescence
emission intensity at 342 nm for wt huMIF, 350 nm for ∆C5
huMIF1-109 and 312 nm for ∆C10 huMIF1-104) as a function
of GdnHCl concentration.
1-Azido-5-naphthalene Sulfonyl (ANS) Binding Studies. To
evaluate the relative exposure of hydrophobic residues within
wt and C-truncated mutants, 7 µM of purified and dialyzed
proteins (in PBS 1X) were incubated for 15 min in the
presence of 50 µM of ANS at RT. A stock ANS solution of
10.54 mM in PBS 1X was freshly prepared, and its
concentration was determined by UV using the extension
coefficient of ANS at 351 nm (ε351 nm ) 6240 M-1 cm-1).
Fluorescence intensities were measured by excitation at 410
nm and emission was acquired over a wavelength range of
420-600 nm using a LS 55 Perkin-Elmer fluorescence
spectrometer.
Quaternary Structure Determination by Size Exclusion
Chromatography (SEC) and Analytical Ultracentrifugation
(AUC). Size exclusion chromatography experiments were
performed on purified samples using an analytical Superdex
75 10/30 column which has an optimal separation range of
peptides and proteins with molecular weight ranging from 3
to 70 kDa. The column was equilibrated with 10 mM Tris
buffer (pH 7.6), and MIF samples (12 µM in PBS 1X) in
volumes of 0.5 mL were injected onto the column and eluted
at a flow rate of 0.4 mL/min in a Waters 2795 analytical
HPLC system equipped with a photodiode array detector.
Analytical ultracentrifugation experiments were performed
on purified and dialyzed MIF samples (12 µM in PBS 1X)
on a Beckman Optima XL-A analytical ultracentrifuge.
Sedimentation velocity experiments were carried out at 20
°C using 380-400 µL of protein solution. Data were
recorded at rotor speeds of 50 000 rpm in continuous mode
at 21 °C with a step size of 0.003 cm. The experimentally
determined partial specific volume of 0.765 mg/mL was used
for calculating the molecular weights of wt and mutants
huMIF (36). Given that this value was determined only for
wt huMIF and for comparison purposes, the molecular
weights of the mutants were also determined using the
calculated (using the program SEDNTERP (36)) partial
specific volumes of 0.7347 mL/g, 0.7364 mL/g, and 0.7332
mL/g for ∆C5 huMIF1-1.09, ∆C10 huMIF1-104 and P107
huMIF. The sedimentation velocity absorbance profiles were
analyzed as a c(s) distribution of the Lamm equation using
SEDFIT (37). To obtain the molecular weights, the molar
mass distributions c(M) were obtained by transforming the
corresponding c(s) using SEDFIT.
Light Scattering. Static light scattering was used to probe
the oligomerization state of wt and C-terminal deletion
mutants of MIF. All measurements were performed at room
temperature on a DAWN HELLIOS multiangle light scat-
tering detector (Wyatt Technology Corp, Santa Barbara CA)
online with a size exclusion chromatography column. The
system is also equipped with UV and refractive index
detectors. 50-100 µL of sample in SEC buffer was injected
onto Superdex 75 10/30 column and eluted at a flow rate of
0.5 mL/min. Absolute MWs were determined using ASTRA
version 5.3 from Wyatt Technologies.
NMR Spectroscopy. NMR spectra were acquired at 27 °C
on Bruker Avance 600 and 800 MHz NMR spectrometers
using a triple-resonance cryoprobe equipped with z-axis self-
shielded gradient coils. Wt human MIF measurements were
done on a 100 µM samples. For triple-resonance experiments,
∆C5 huMIF1-109 and ∆C10 huMIF1-104 were concentrated
to 200 µM, whereas HSQCs of the mutants were recorded
at 60 µM protein concentration. To probe for aggregation,
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additional NMR spectra were recorded for ∆C10 huMIF1-104
at a concentration of 10 µM. All samples were in 20 mM
Na2HP04, 0.5 mM EDTA, 0.02% NaN3 (pH 7.0) and 10%
D2O. Two-dimensional 1H-15N heteronuclear single quan-
tum coherence (HSQC) spectra were recorded using 256 ×
1024 complex data points in F1 and F2 dimensions with a
relaxation delay of 1.0 s. 48 scans per increment were
recorded for the wt protein whereas 64 scans were recorded
for the truncation mutants. Spectral widths were 2200 and
8950 Hz in 15N and 1H dimensions, respectively. For
backbone assignment of ∆C5 and ∆C10 truncated huMIF,
3D HNCA experiments were recorded on a 800 MHz
spectrometer using a cryoprobe. Spectra were processed with
XWIN-NMR and NMRPipe. Visualization and manipulation
were performed using the public domain graphics program
Sparky 3.
MIF Receptor Binding Assay. Recombinant, soluble hu-
MIF receptor ectodomain (sCD7473-232) was cloned and
purified as described in ref 38 and used to coat 96 well plates
by incubation at 4 °C overnight. Plates were washed 4 times
with TTBS (pH 7.4) and blocked with superblock buffer
(PIERCE) for 1 h at room temperature. Biotinylated huMIF
(Roche Molecular Biochemical) was prepared and added
together in triplicate wells with increasing concentrations of
purified native huMIF (33), heat-denatured huMIF, or test
MIF proteins. Incubation was at room temperature for 2 h.
After washing wells 4 times with TTBS (pH 7.4), strepta-
vidin-conjugated alkaline phosphatase (R&D) was added,
incubation continued for an additional hour, and the wells
washed and bound complexes detected by adding p-nitro-
phenyl phosphate (Sigma). Absorbance was read at 405 nm
using a DYNATECH, MR5000 plate reader, and values
plotted as percent OD405 relative to wells containing bioti-
nylated-MIF alone. The plots shown are representative of at
least three assays, and each plotted point depicts a SEM <
10%.
Mass Spectrometry. Mass spectrometric analysis of huMIF
was performed by matrix-assisted laser desorption ionization
MALDI MS using a linear positive ion mode on ABI 4700
(PAF Lausanne). Linear mode calibration was applied with
single point on R-synuclein wild type (MH+: 14461.19).
Sample preparation: After desalting huMIF sample on a
StageTip C18 (Proxeon), one volume of sample was mixed
with one volume of matrix. Matrix solution consists of 20
mg/mL of dihydroxybenzoic acid in 1% phosphoric acid/
acetonitrile 1/1. A two-layer sample preparation has been
selected for the MW analysis.
Computational Studies. Classical molecular dynamics
(MD) simulations were based on the X-ray structure of
huMIF (pdb code 1GD0) determined at 1.5 Å resolution (27);
residues corresponding to the His-tag sequence were removed
from the pdb file. Three model systems of the trimeric
structure of MIF were considered: wt huMIF, ∆C5 hu-
MIF1-109, and ∆C10 huMIF1-104. Protonation states of
titratable groups were assigned according to empirical pKa
prediction (39) and Poisson-Boltzmann calculations (54).
Chlorine anions were added to neutralize the charge of the
models. Wt huMIF, ∆C5 huMIF1-109, and ∆C10 huMIF1-104
models were solvated by 3 chlorine anions and 13654, 13483
and 13745 water molecules, respectively. MD calculations
were carried out with the SANDER module of the AMBER8
suite of programs (40). The AMBER (parm98) (41) and
TIP3P (42) force fields were used for the protein atoms and
for water, respectively. Periodic boundary conditions were
applied. Electrostatic interactions were calculated with the
Ewald particle mesh method (43). A 12 Å cutoff for van
der Waals interactions was used. Bonds involving hydrogen
atoms were constrained using the SHAKE algorithm (44).
A time step of 1.5 fs was used during the dynamics. Constant
temperature and pressure conditions were achieved by
coupling the systems with a Berendesen thermostat and
barostat. Our computational protocol for the three models
was the following: (i) equilibration of the solvent by 200 ps
of MD at ambient conditions (310 K temperature and 1 atm
pressure), while keeping the protein fixed; (ii) energy
minimization of the entire system through 25 steepest descent
steps and 30000 conjugate gradient steps, progressively
allowing hydrogen atoms, side chain atoms and backbone
atoms to move; (iii) thermalization of the whole systems by
MD calculations: 30 ps from 0 to 50 K, 45 ps from 50 to
150 K, 70 ps from 150 to 310 K; (iv) 10 ns of MD
simulations at 310 K and 1 atm.
RESULTS
Mapping of Intersubunit Interactions InVolVed in Trimer
Formation and Stability. To identify key intersubunit contacts
that are important in modulating trimer formation and
stability, we examined high-resolution X-ray structures of
MIF and analyzed hydrogen-bonding, hydrophobic and salt-
bridge interactions that define the monomer-monomer
interfaces. The crystal structures reveal several intersubunit
interactions that are likely to contribute to trimer formation
and stability (Figures 1B and S1; see Supporting Informa-
tion): (1) Formation of intermolecular antiparallel -sheet
between -strand 3 of one monomer and the edge -strand
2 of the neighboring monomer (Figures 1B and S1; see
Supporting Information). This -sheet is stabilized mainly
by hydrogen bond interactions between residues Val39 (in
2, monomer 1) and Ala48 (in 3, monomer 2). (2) The
C-terminal -hairpin comprising residues 105-114 is in-
volved in several intersubunit interactions and could con-
tribute to trimer stabilization through two types of contacts:
(i) intersubunit -sheet formation mediated by hydrogen
bonding between Asp105 and Gly107 in the C-terminal
-strand 6 and Ile96 and Tyr98 within the inner -strand
5 of the neighboring subunit, (Figures 1B and S1; see
Supporting Information); (ii) by a salt-bridge interactions
between the carboxylate group of the C-terminal residue
Ala114 and the side-chain of Arg73, located on the R-helix
H2 of the neighboring subunit (Figures 1B and S1; see
Supporting Information).
Comparison of the crystal structures of human and rat MIF
reveals that the rat MIF trimer is virtually identical to that
of huMIF despite the fact that its entire C-terminal region
(corresponding to residues 105-114 in human MIF) appears
to be unstructured (45). These findings suggest that the
C-terminal region may not be required for trimer formation
and stability. However, the location of the active site at the
monomer-monomer interface and the interactions between
the C-terminal strand 6 and 5, which contains several
residues that participate in substrate recognition and catalysis
(Figure 1C), suggest that the C-terminal region may signifi-
cantly influence the structural and dynamic properties as well
as biochemical and biological activities of MIF.
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In order to understand the relative importance of the
various interactions involving the C-terminal region in the
oligomerization, thermodynamic stability, and function of
huMIF, we used site-directed mutagenesis to generate single
site and C-termini-truncated mutants of huMIF and charac-
terized these mutants using an array of biochemical and
biophysical methods. To probe the importance of the salt-
bridge interaction between Ala114 and Arg73, we generated
a mutant where the last five amino acids (∆NSTFA),
corresponding to the -strand 7, were removed (Figure 1B).
We hypothesized that this would significantly increase the
distance between the two interacting groups and disrupt the
formation of the salt bridge. To determine the effect of
disrupting all stabilizing interactions involving the C-terminal
-strands (salt-bridge interaction between Ala114 and Arg73
as well as the intersubunit hydrogen bonds between -strands
6 and 5), we generated a mutant where the entire -hairpin
comprising the -strands 6 and 7 (∆NVGWNNSTFA) was
removed (Figure 1B). To determine the contribution of the
hydrogen bonding interactions between Ala48 (3) and
Val39 (2), we generated a mutant in which Ala48 was
replaced by the secondary structure breaker proline residue
(A48P).
Protein Expression and Purification. Wt and mutant
huMIF were expressed in E. coli BL21 (DE3) cells and
purified to purity using the protocol described in Materials
and Methods. The wt and C-terminal deletion mutants
expressed as soluble proteins and migrated as a single band
on reducing SDS-PAGE. The identity and purity of
expressed proteins were verified by SDS-PAGE/silver
staining and Western blot and mass spectrometry (data not
shown). MALDI-TOF analyses revealed single peaks cor-
responding to the predicted molecular weight of wt huMIF
(12.345 kDa), ∆C5 huMIF1-109 (11.825 kDa), and ∆C10
huMIF1-104 (11.254 kDa). The A48P huMIF mutant ex-
pressed in E. coli as inclusion bodies, supporting the
conclusion that it failed to fold properly. It is also possible
that A48P aggregation is mediated by misfolding of the
trimer, although attempts to reconstitute the native trimer
from purified and lyophilized protein were not successful.
This observation suggests that the intersubunit -sheet
involving the -strands 3 from one monomer and 2 from
the adjacent monomer contribute significantly to trimer
formation and stability.
Probing the Effect of Carboxy-Terminal Truncation on the
Functional Properties of huMIF. To determine the effect of
the carboxy-terminal deletions on the functional properties
of huMIF, we compared the enzymatic activity and receptor
(CD74) binding properties of wt and mutants huMIF.
Catalytic ActiVity. The catalytic activity of wt and mutant
huMIF were studied using D-dopachrome and phenylpyruvate
as substrates. Both ∆C5 huMIF1-109 and ∆C10 huMIF1-104
did not show any detectable tautomerase activity with
D-dopachrome (Figure 2A) and phenylpyruvate (Figure 2B)
as substrates. Even at higher protein concentrations (up to
10 µM) both mutants exhibited very minimal, if any, catalytic
activity.
Receptor (CD74) Binding. Although the molecular mech-
anisms underlying the biological functions of MIF remain
poorly understood, MIF’s binding to CD74, a type II
transmembrane protein, was demonstrated to be essential for
several of MIF’s cellular functions such as activation of ERK
1/2 MAPK cascade (38) and cell proliferation (46). More-
over, recent studies by Meyer-Siegler et al. showed that
MIF-CD74 interaction mediates bladder inflammation and
inhibition of MIF or CD74 attenuates growth and invasion
of prostate cancer cells (47, 48). Interestingly, all three
proteins wt huMIF, ∆C5 huMIF1-109, and ∆C10 huMIF1-104
displayed virtually identical binding to CD74 (Figure 2C-E),
indicating that the C-terminal residues 105-114 may not
be directly involved in the binding to CD74.
Biophysical Characterization of Wt and C-Terminal
Truncated huMIF Mutants. In order to understand the
molecular basis underlying the loss of enzymatic activity
upon deletion of the C-terminal residues 110-114 (6) and
105-114 (6 and 7), we probed the effect of C-terminal
truncation on the conformational properties and thermody-
namic stability of huMIF by far-UV circular dichroism. The
CD spectra of the wt and C-terminal deletion mutants showed
a broad negative ellipticity between 225 and 208 nm,
consistent with the presence of a mixture of R-helix and
-sheet structures (Figure 3A). The spectra of both ∆C5
huMIF1-109 and ∆C10 huMIF1-104 were shifted toward lower
wavelengths and exhibited a slight decrease in ellipticity at
218-220 nm, consistent with the expected disruption of the
C-terminal -hairpin upon deletion of the C-terminal -strands.
The C-Terminal Deletion Mutants Are Thermodynamically
Less Stable than Wt huMIF. To understand the role of the
C-terminal region in modulating the stability of MIF, we
compared the stability of wt and C-terminal deletion mutants
to thermal and GdnHCl induced denaturation. Thermal
denaturation of wt and C-terminal deletion mutants monitored
by far-UV CD (at 218 nm) showed a cooperative unfolding
with increasing temperature. As shown in Figure 3B, ∆C5
huMIF1-109, and ∆C10 huMIF1-104 began to undergo con-
formational changes at lower temperatures than wt huMIF
(Tm ) 79 °C) and displayed Tm values of 69.5 and 71.5 °C
respectively. Over the concentration range of 2.5-50 µM,
we did not observe any change in the Tm values for all three
proteins (Figure S3, see Supporting Information). The
thermal denaturation of all three proteins was irreversible
due to protein aggregation which occurs upon unfolding of
MIF.
To further investigate the effect of the carboxy terminus
on trimer stabilization and conformational stability of huMIF,
GdnHCl-induced unfolding studies were performed on wt
and C-terminal truncated huMIF mutants. GdnHCl-induced
unfolding of MIF was monitored by far-UV CD and
fluorescence spectroscopy. Wt and mutants huMIF exhibited
a cooperative unfolding curves with midpoints of unfolding
(Cm) of 2.14 M, 1.82 and 2.06 M GdnHC1 for wt huMIF,
∆C5 huMIF1-109, and ∆C10 huMIF1-104, respectively (Figure
3C), in agreement with the order of stability determined by
thermal denaturation. GdnHCl-induced denaturation was also
studied by fluorescence spectroscopy. MIF has only one
tryptophan (W108) residue that is located within the C-
terminal region under investigation; only ∆C10 huMIF1-104
lacks W108. Therefore, we also monitored the unfolding of
all proteins using excitation wavelengths of 280 nm. Using
an excitation wavelength of 280 nm, we obtained midpoints
of denaturation of 1.80, 1.20 and 2.00 M GdnHCl for wt
huMIF, ∆C5 huMIF1-109, and ∆C10 huMIF1-104, respectively
(Figure 3D). Using an excitation wavelength of 295 nm, we
obtained similar midpoints of denaturation for wt huMIF
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(1.80 M) and ∆C5 huMIF1-109 (1.2 M). Interestingly, the
Cm values obtained by fluorescence spectroscopy are slightly
lower than those obtained by far-UV CD, possibly due to
the fact that the residues being monitored (Tyr and Trp) are
located in regions that are more accessible and conforma-
tionally less stable.
ANS Binding. To further probe tertiary structure changes
induced by deletion of the C-terminal residues, we performed
ANS binding studies on the wt and C-terminal huMIF
mutants. ANS binds to accessible hydrophobic surfaces of
proteins and thus provides a measure of the relative exposure
of hydrophobic residues. ANS binding is reported by an
increase in ANS fluorescence emission when excited at 410
nm as well as by a blue shift in the fluorescence emission
maximum. ANS binding was determined under the same
experimental conditions (i.e., protein concentrations, pH,
buffer conditions, and temperature). Figure 3E demonstrates
that both mutants exhibit higher fluorescence intensity than
the wt protein with ∆C5 huMIF1-109 exhibiting the highest
ANS fluorescence (∆C5 huMIF1-109 > ∆C10 huMIF1-104
> wt huMIF), suggesting an increased exposure of the
hydrophobic surfaces of ∆C5 huMIF1-109 compared to ∆C10
huMIF1-104 and wt huMIF, consistent with simulations,
where the ∆C5 huMIF1-109 mutant is less packed than both
the wt and ∆C10 huMIF1-104 isoforms (see below).
Probing the Effect of the C-Terminal Deletions on the
Oligomerization State of MIF. The loss of catalytic activity
and decreased stability of the C-terminal deletion mutants
combined with the fact that the tautomerase active site is
formed at the monomer-monomer interfaces of the trimer
(24) led us to hypothesize that the loss of intersubunit
stabilizing interactions involving the C-terminal residues
105-114 may result in disruption of the native quaternary
structure of MIF. To test this hypothesis we compared the
quaternary structure distribution of wt huMIF, ∆C5 hu-
MIF1-109, and ∆C10 huMIF1-104 at 12 µM by sedimentation
velocity analytical ultracentrifugation. Figure 4B shows that
wt and C-terminal deletion mutants huMIF sediment pre-
dominantly (>95%) as a single species with experimental
sedimentation coefficients of 3.15 S ((0.1 S) for wt huMIF,
3.06 S ((0.1 S) for ∆C5 huMIF1-109 and 2.97 S ((0.1 S)
for ∆C10 huMIF1-104. Using the partial specific volume
measured by Philo et al. (0.765 mL/g (36)) we obtained
molecular weights of 37.4 kDa, 39.1 kDa and 38.2 kDa, for
FIGURE 2: Removal of the C-terminal amino acids corresponding to 6 and/or 7 strand(s) abolishes the enzymatic activity of MIF (A, B),
but has no effect on receptor binding (C-E). D-Dopachrome (A) and phenylpyruvate (B) tautomerization in the presence of wt huMIF
(solid line), ∆C5 huMIF1-109 (dashed line) and ∆C10 huMIF1-104 (dotted line). Thin solid lines correspond to the substrate in the absence
of MIF. Wt huMIF and C-truncated mutants exhibit similar binding to CD74 receptor. All three proteins (wt huMIF (C), ∆C5 huMIF1-109
(D) and ∆C10 huMIF1-104 (E)) bind equally to CD74. Under denaturing conditions, MIF does not bind to CD74. CD74 binding to MIF was
measured as a percentage of OD405 relative to biotinylated-MIF alone (see Materials and Methods).
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wt, ∆C5 huMIF1-109, and ∆C10 huMIF1-104, respectively.
Using the partial specific volume calculated from the amino
acid composition, we obtained molecular weights of 35.4
kDa, 35.9 kDa and 33.8 kDa for wt, ∆C5 huMIF1-109, and
∆C10 huMIF1-104 respectively. Thus, our findings are fully
consistent with a strongly associated trimeric quaternary
structure of wt, as reported previously (36, 49), and mutant
proteins. The slight decrease in the sedimentation coefficient
values for the carboxy deleted proteins may reflect the small
change in molecular weight and/or altered conformational
properties of the mutants. In the case of the ∆C10 hu-
MIF1-104, two additional minor species with average s values
of 1.5 S ((0.1 S) and 5 S ((0.1 S) corresponding to
monomeric and higher order aggregates were consistently
detected in all ∆C10 huMIF1-104 samples. These results
suggest that the ∆C10 huMIF1-104 trimer exhibits slight
decreased stability and may undergo aggregation upon
dissociation into monomers. To determine if the effect of
C-terminal truncation on MIF oligomerization is concentra-
tion dependent, we performed sedimentation velocity studies
on all three proteins over the concentration range of 2.5-50
µM. At all concentrations, wt and C-terminal mutants
sedimented predominantly as a single species with s values
and molecular masses corresponding to those of the corre-
sponding trimer (Figure S4, see Supporting Information).
To further probe the effect of C-terminal deletions on the
oligomerization state of MIF, we determined the quaternary
structure distribution of wt, ∆C5 huMIF1-109 and ∆C10
huMIF1-104 by analytical SEC and native PAGE gel elec-
trophoresis. In nondenaturing gels wt huMIF migrated as two
bands, whereas ∆C5 huMIF1-109 and ∆C10 huMIF1-104 run
as a single band. Both mutants exhibited quite similar
electrophoretic mobility to one of the bands of wt MIF
(Figure 4C). It is noteworthy that removing the C-terminal
amino acids 105-114 does not alter the charge distribution
and PI of the mutants relative to the wt protein. Analysis of
the same samples by analytical SEC (Superdex 75) is
consistent with the native PAGE and demonstrates that wt
huMIF elutes mainly as two peaks with elution volumes of
13.8 and 15.8 mL (Figure 4D). The C-terminal deletion
mutants ∆C5 huMIF1-109 and ∆C10 huMIF1-104 elute
predominantly as a single peak with an elution volume of
11.5 mL. To better assess the true oligomerization state of
wt and C-terminal mutants the samples corresponding to each
peak were reinjected into a Superdex 75 column and analyzed
by light scattering upon elution (Figure 5). These studies
show that the eluting species do not interconvert in the time
scale of our experiments and confirmed that all of the peaks
correspond to trimeric forms of MIF (Figure 5). The fact
that the observed differences in catalytic activity, electro-
phoretic mobility, SEC elution profiles, and thermodynamic
stability between the C-terminal deletion mutants occur in
the absence of any change in the oligomerization state of
the protein suggests that removal of the C-terminal residues
FIGURE 3: Truncations of the C-terminal residues 105-114 alter the tertiary structure of MIF and decrease its stability: solid line, wt
huMIF; dashed line, ∆C5 huMIF1-109; dotted line, ∆C10 huMIF1-104. (A) Far UV/CD spectra of wt huMIF (17 µM), ∆C5 huMIF1-109 (25
µM) and ∆C10 huMIF1-104 (20 µM) in PBS 1X, pH 7.4. (B) Thermal denaturation of wt huMIF, ∆C5 huMIF1-109 and ∆C10 huMIF1-104.
(C) GdnHCl-induced unfolding of wt huMIF, ∆C5 huMIF1-109 and ∆C10 huMIF1-104 monitored by far UV/CD (218 nm) (C) and fluorescence
(D). All unfolding studies were performed at protein concentration of 14 µM. The change in fluorescence as a function of GdnHCl was
monitored at 342 nm for wt huMIF, 350 nm for ∆C5 huMIF1-109 and 312 nm for ∆C10 huMIF1-104 using an excitation wavelength of 280
nm. (E) ANS binding to wt huMIF, ∆C5 huMIF1-109 and ∆C10 huMIF1-104 monitored by ANS fluorescence emission at 490 nm (excitation
at 410 nm).
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110-114 or 105-114 results in significant changes in the
tertiary structure of the trimer.
Disruption of the C-Terminal -Hairpin Produces Similar
Effects As RemoVal of the C-Terminal Residues 105-114.
To determine whether the loss of catalytic activity and
decreased thermodynamic stability in the case of both
deletion mutants is due to removal of these residues or simply
disruption of the C-terminal -hairpin, we generated an MIF
variant (P107) in which a proline residue was inserted at
position 107 (Figure 6). This insertion disrupts key hydrogen
bonding interactions involved in the stabilization of the
C-terminal -hairpin (Figure 6A). Similar to the C-terminal
deletion mutants, the P107 variant showed a CD spectrum
shifted toward lower wavelengths (Figure 6B), consistent
with loss of the C-terminal -hairpin, and a decreased
thermodynamic stability (Figure 6C) as assessed by the Tm
value (72 °C). On the other hand P107 huMIF sedimented
predominantly as a single species with sedimentation coef-
ficient of 3.0 ( 0.1 S (MW ) 38.12 kDa) by sedimentation
velocity (Figure 6D). Finally, biochemical studies revealed
that of P107 variant exhibits very minimal catalytical activity
(Figure 6E).
C-Terminal Truncations Result in Significant Perturbations
of the Tertiary Structure of MIF without Affecting the
Oligomerization State of the Protein. To test our hypothesis
and directly probe the influence of the C-terminal truncation
on the structure of MIF, we applied NMR spectroscopy to
wt and mutant MIF. The 2D 1H-15N HSQC of wt huMIF
closely resembles previously observed NMR spectra (30, 50)
(Figure 7A). 100 out of 107 expected signals arising from
backbone amide-amide proton pairs could be assigned on
the basis of published resonance assignments (30, 50) (Figure
7A). Deletion of 10 residues at the C-terminus induced
dramatic changes in the NMR spectra (Figure 7A). The
number of backbone signals was reduced to ∼70. Almost
all resonances were broadened and shifted compared to wt
MIF. Using 3D HNCA experiments, 26 of the backbone
resonances could be sequence specifically assigned. The
residues for which sequence specific assignments could be
obtained were distributed along the primary sequence. For
FIGURE 4: C-Terminal truncations do not affect the quaternary structure of huMIF. (A) Sedimentation velocity profiles of wt huMIF (12
µM). Scans for analysis were recorded every 3 min; for clarity, only 9 representative scans 20-30 min apart are shown. (B) Sedimentation
coefficient distributions were obtained from analysis of the sedimentation profiles of wt and C-terminal mutants at 12 µM using the C(s)
distribution as a variant of Lamm equation solutions using SEDFIT as described in Materials and Methods: solid line, wt huMIF; dashed
line, ∆C5 huMIF1-109; dotted line, ∆C10 huMIF1-109:. (C) Native PAGE gel of purified wt huMIF, ∆C5 huMIF1-109, and ∆C10 huMIF1-104.
(D) Analytical SEC profiles of wt huMIF (solid line), ∆C5 huMIF1-109 (dashed line) and ∆C10 huMIF1-104 (dotted line).
FIGURE 5: Wt and C-truncated huMIF exist as stable trimers. Light
scattering analyses of the reinjected peak 1 (black line) and peak 2
(green line) from preparative SEC of wt huMIF, ∆C5 huMIF1-109
(blue line) and ∆C10 huMIF1-104 (red line). The individual data
points show the molecular weight at each point in the chromatogram.
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Gly51, two signals were observed suggesting that this residue
exchanges between two different conformations.
NMR chemical shifts, in particular of CR atoms, are very
sensitive probes of secondary structure. These shifts show
distinct deviations from random coil values for both wt and
mutants MIF (Figure 7C). In the case of wt huMIF, the CR
secondary structure-dependent chemical shifts are in good
agreement with the location of secondary structure elements
observed in the crystal structure of wt MIF (27). In ∆C5
and ∆C10 truncated huMIF, very similar CR secondary
FIGURE 6: Disruption of the C-terminal -hairpin produces similar effects as removal of the C-terminal residues 105-114. (A) Pro107
variant was generated by insertion of a proline between residues Val106 and Gly107 to disrupt key hydrogen bonding interactions involved
in the stabilization of the C-terminal -hairpin. Far UV/CD spectra (B) and thermal denaturation (C) of wt huMIF (solid line) and P107
huMIF (dashed line). (D) Sedimentation coefficients distributions of wt huMIF (solid line) and P107 huMIF (dashed line). Far UV/CD,
thermal stability and sedimentation velocity experiments were performed on the same dialyzed sample at 15 µM in PBS 1X. (E) D-Dopachrome
(278 µM) tautomerization in the presence of 19 nM of wt huMIF (solid line), 25 nM of P107 huMIF and 90 nM P107 huMIF (dotted lines).
Dashed line corresponds to the substrate in the absence of MIF.
FIGURE 7: Secondary structure of wt, ∆C5 huMIF1-109 and ∆C10 huMIF1-104. (A) Superposition of two-dimensional 1H-15N HSQCs of wt
(black) and ∆C10 huMIF1-104 (red). Resonance assignments of strongly shifting resonances are indicated. (B) 1H/15N chemical shift differences
between wt and ∆C10 huMIF1-104. (C) CR secondary chemical shifts observed in wt (black), ∆C5 huMIF1-109 (green) and ∆C10 huMIF1-104
(red). Secondary structure elements observed in the crystal structure of wt MIF are indicated.
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structure-dependent chemical shifts were observed for those
residues that were visible in the NMR spectra and that could
be sequence specifically assigned (Figure 7C). In all -strands
except 3 and all R-helices except helix H2 at least a single
residue could be assigned in the deletion mutants. This
indicates that the secondary structure elements in ∆C5
huMIF1-109 and ∆C10 huMIF1-104 are overall retained in
agreement with CD measurements, as also found in our MD
runs (see below). In -strand 5 the observed secondary
chemical shifts are smaller than those observed for the wt
protein indicating that the last -strand before the position
of truncation is destabilized. This is also found in our MD
run, where residues 95-97 temporarily lose the -sheet
conformation (see below).
The 2D 1H-15N HSQC spectra of both C-truncated huMIF
were very similar (Figure 8A). Both the positions and line
widths of signals were very similar. Interestingly, the signal
of Ile64, which was not visible for ∆C5 huMIF1-109, was
observable in the HSQC of ∆C10 huMIF1-104 at a similar
position as observed in wt huMIF. In addition, some other
residues showed lower signal intensities in ∆C5 huMIF1-109
when compared to ∆C10 huMIF1-104 (Figure 8B). In
particular, -strands 4 (residues C59, S63 and I64) and 5
(residue N97) were affected by increased chemical exchange
in ∆C5 huMIF1-109. Note that reducing the concentration of
∆C10 huMIF1-104 from 60 to 10 µM did not strongly change
the position and line width of signals in the 2D 1H-15N
HSQC, suggesting that the changes observed in the NMR-
spectra of MIF upon truncation are not due to an altered
aggregation propensity.
Molecular Dynamics Simulations. In silico studies were
employed to provide insight into the structural consequences
of deleting the C-terminal residues 105-114, and 110-114
and their contribution to the structure and stability of huMIF.
Three independent MD simulations of 10 ns were performed
for the wt huMIF trimer and the C-terminal deletion mutants
∆C5 huMIF1-109 and ∆C10 huMIF1-104. Although the
simulation times are relatively short, we observe, for both
forms of C-truncated huMIF, an increase of the values
reached by the rmsd (1.8 for the wt huMIF, against 2.7 Å
for ∆C5 huMIF1-109 and 2.3 Å for ∆C10 huMIF1-104) (Figure
9A). In the case of ∆C5 huMIF1-109, the profile of the rmsd
is slightly divergent, which suggests that the structure might
undergo further conformational modifications on a longer
time-scale. The root-mean-square fluctuations of the residues
in both mutant huMIFs are qualitatively similar to those of
the wt, but show higher deviations in the region between
residues 65 and 90, corresponding to helix H2 (Figure 1B),
suggesting accumulation of mechanical strain in that region.
These findings are related to the removal of the native salt
bridge occurring between the carboxyl group of the C-
terminal residue Ala114 of one monomer and the side-chain
of Arg73, located at the second turn of the helix H2 of the
neighboring monomer. The carboxy-terminal region also
shows a much higher mobility than in the wt huMIF (Figure
9B).
Although deletion of C-terminal -strands is expected to
disrupt all the local intersubunit interactions, including the
C-terminal salt bridge, the molecular simulation data revealed
that the C-terminal salt bridge is maintained in both truncated
huMIF mutants (Figure 10A-C). In ∆C5 huMIF1-109 the
new C-terminal residue is Asn109; the distance in the wt
trimer (27) between the C-terminus of Asn109 and the side
chain of Arg73 is ∼12 Å. However, upon deletion of the
last 5 amino acids, our simulations show that a new salt
bridge can still be formed. This is facilitated by rotation of
the Arg73 side chain (Figure 10B), which can bring the two
charged residues back to the typical salt-bridge distances
(Figure 10D). In the case of ∆C10 huMIF1-104, the C-
terminal residue Ala104, which in wt huMIF is located at
the loop that links the C-terminal hairpin to the rest of the
protein, is still capable of forming a salt bridge with Arg73
(Figure 10C) (initial crystallographic distance in the wt
between Ala104 and Arg73 is 7 Å). Statistical distribution
FIGURE 8: Comparison of the structural properties of ∆C5 huMIF1-109 and ∆C10 huMIF1-104 with single-residue resolution. (A) Superposition
of 1H-15N HSQCs of ∆C5 huMIF1-109 (blue) and ∆C10 huMIF1-104 (red). Resonances that could be assigned are labeled with residue
number. (B) Ratio of signal intensities of resonances observed for ∆C5 huMIF1-109 and ∆C10 huMIF1-104 in 1H-15N HSQC spectra.
Secondary structure elements observed in the crystal structure of wt MIF are indicated. (C) Ribbon diagram of the crystal structure of MIF
(pdb 1GD0) with residues that could be assigned in ∆C10 huMIF1-104 in red. In blue, residues are highlighted for which the intensity ratio
shown in (B) was below 0.8. -Strands 6 and 7 are shown in green and orange. Gly107 and Ile96 that form a hydrogen bond are
highlighted.
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of the C-terminus-Arg73 side-chain distances in all 3 proteins
(Figure 10D) shows clearly a clear sharp peak at around
4-4.5 Å. Integration of this first peak confirms that wt
huMIF has the most stable ionic interaction at the C-terminus
(i.e., the salt bridge forms during more than 70% of the total
MD simulation time (10 ns)); ∆C5 huMIF1-109 shows a less
stable interaction with the salt bridge being formed during
the 56% of the total MD simulation time, while ∆C10
huMIF1-104 is only marginally more stable than ∆C5
huMIF1-109 (59% of the total MD simulation time). Due to
the topological proximity of the C-terminus to Arg73 in both
C-truncated mutants, the retained salt bridge causes an
accumulation of mechanical strain in the helix H2 (Figure
S2; see Supporting Information).
MD Simulations Support a Linkage between the Confor-
mational Flexibility of the C-Terminus and Catalytic ActiVity
of MIF. The catalytic pocket of huMIF is located at the
interface between two monomers. The high resolution X-ray
structure of MIF bound to its unnatural substrate hydrox-
yphenyl pyruvate (HPP) in the catalytic active site reveals
that interactions with the substrate involve amino acids from
two adjacent monomers, more specifically Pro1, Lys32 and
Ile64 from one monomer and Tyr95 and Asn97 from the
neighboring monomer. As the protein scaffold is rather rigid,
and does not undergo major conformational changes upon
substrate binding, the orientation of these residues in the wt
apoprotein in the X-ray structure is very similar to that in
the protein/HPP complex, and is conserved during the 10 ns
of our MD simulations.
The catalytic pocket of huMIF is topologically located next
to the salt bridge involving Arg73. Our simulations show
that the mutated forms of huMIF undergo strong conforma-
tional changes in the catalytic pocket. In particular, in both
mutants the helix H2 bends, losing the R helix for a 3-10
helical or a coil structure, between Gln71 and Ser76 (Figure
S2; see Supporting Information). The orientations of side
chains of residues involved in forming the catalytic active
site are dramatically altered in both carboxy truncated
mutants and predict drastic effects on the tautomerase activity
of these proteins.
Superimposition of the structures of wt and C-terminal
deletion mutants shows that both ∆C5 huMIF1-109 and ∆C10
huMIF1-104 structures deviate from the wt huMIF one (rmsd
of 3.60 Å and 2.18 Å respectively) (Figure 11). During our
MD simulations, we observe an overall enlargement of the
catalytic pocket in ∆C5 huMIF1-109 (Figure 11A). This event
was monitored by computing the radial distribution function
(RDF) between the nitrogen atom of Pro1, located ap-
proximately at the center of the catalytic pocket, and the
water oxygen atoms. Spatial integration of the RDF makes
evident that the average number of water molecules in the
pocket of ∆C5 huMIF1-109 increases with respect to the wild
type (7.5 and 8.7 water molecules for the wt huMIF and
∆C5 huMIF1-109, respectively) (Figure 11C,D). In the case
of ∆C10 huMIF1-104, we instead observe a reduction of the
solvent-accessible space in the catalytic pocket (Figure
11B-D) (6.4 water molecules). In addition, we report a
different packing of the side-chain of Met101 (Figure
10E-G), which temporarily intercalates between the catalytic
residues Tyr95 and Asn97 in the binding site. Such intrusion
clearly interferes with the binding properties of the substrate,
since the cleft between Tyr95 and Asn97 is typically
occupied by its aromatic ring. Furthermore, both superim-
positions of the mutant structures to the wild type one, show
a flipping of Asn97 side chain in both C-truncated huMIF
forms with respect to wt huMIF (Figure 11A,B), which
implies a dramatic modification of the characteristic hydrogen-
bond patterns in the catalytic pocket. The radical change of
the relative positions of the catalytic amino acids must have
a strong disruptive impact on the enzymatic activity of the
protein, as assessed in our experiments. It is noteworthy that
significant structural deviations occur during the simulation
in the region comprising residues 50-104 of the C-terminal
mutants (Figure 9) suggesting that decreased stability and
loss of catalytic activity may be the result of both local and
global conformational changes in the trimer.
DISCUSSION
In this study, we sought to provide some insight into the
structural and molecular determinants involved in regulating
the structure and activity of MIF. We focused on elucidating
the relative contribution of the various intersubunit interac-
tions, suggested by the X-ray and MD-solution structures
of the trimer, on the structural and functional properties of
MIF.
The C-terminal region of MIF, in particular residues
105-114, is highly conserved (>95%) across different
species (Figure 1D), suggesting that it may play critical roles
in modulating the structure and activity of MIF in ViVo. This
notion is supported by high-resolution X-ray structures of
MIF demonstrating that this region is highly ordered and
participates in several intersubunit interactions at the
FIGURE 9: Root-mean-square deviations (rmsd) of the backbone
atoms (A) and root-mean-square fluctuations (rmsf) per amino acid
(B) of wt huMIF and C-terminal truncated mutants. Black line: wt
protein. Red line: ∆C5 huMIF1-109. Blue line: ∆C10 huMIF1-104.
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monomer-monomer interface (Figure 1B). Furthermore,
previous structure activity studies have suggested that this
region may play an important role in modulating the stability
and oligomerization of MIF (29, 31). We used a battery of
biophysical techniques, biochemical assays and molecular
dynamics simulations to characterize deletion and insertion
mutants of MIF designed to probe the role of the C-terminal
region (residues 105-114) in modulating the conformational
flexibility, tertiary structure, oligomerization state, catalytic
activity, and receptor binding properties of MIF. Our results
FIGURE 10: The salt bridges between the C-terminal carboxylate group and Arg73 are retained in wt (A) and both C-terminal deletion
mutants (B, C). The C-terminal residue and Arg73 are drawn in ball-and-sticks; the rest of the protein is represented by a cartoon. The three
monomers are colored in cyan, green and magenta, respectively. Panel (D) represents the statistical distribution of the salt-bridge distance.
Distance between CR atom of arginine and the carbonyl C atom of the C-terminal residue is reported on the x-axis. The relative probability
density is reported on the y-axis. The histograms correspond to the wt huMIF (black), ∆C5 huMIF1-109 (red) and ∆C10 huMIF1-104 (green).
Panels (E-G) represent the Met101 position in wt huMIF, ∆C5 huMIF1-109 and ∆C10 huMIF1-104 respectively. Met101 is drawn in
ball-and-sticks, Tyr95 and Asn97 are drawn in licorice, and the rest of the protein is represented by a cartoon. The three monomers are
colored in cyan, green and magenta, respectively.
FIGURE 11: Geometrical distortion of the active-site pocket induced by removal of the C-terminal -strands. Superimposition of the binding
site residues in wt huMIF to the same residues in ∆C5 huMIF1-109 (panel A) and ∆C10 huMIF1-104 (panel B). Wt huMIF catalytic residues
are colored in green, and those of the mutated forms are colored according to the standard element code (blue, nitrogen; red, oxygen; gray,
carbon; blank, hydrogen). The two adjacent monomers where the binding residues are located are shown with cartoon, and colored in cyan
and ice-blue respectively. Only monomers from the wt structure are represented for simplicity. (C, D) Radial distribution functions between
Pro1 backbone N atom and water oxygen atoms. The rdf’s (C) and their spatial integrals (D) are reported for the wt huMIF (solid line),
∆C5 huMIF1-109 (dashed line) and ∆C10 huMIF1-104 (dotted line) proteins.
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provide new insight into the structural consequences of
disrupting and/or removing this region and molecular basis
underlying its role in modulating the tertiary structure,
conformational flexibility and activity of MIF.
The catalytic activity of MIF is oligomerization-dependent;
the active sites are formed at the monomer-monomer
interfaces. Therefore, conformational changes in regions
involved in trimer formation and stability should influence
MIF enzymatic activity. In this study, we demonstrate that
the C-terminal region of MIF contributes to tertiary structure
stabilization and thermodynamic stability of MIF and plays
a critical role in modulating its catalytic activity. Removal
of the last 5-10 (110-114 or 105-114) C-terminal amino
acid residues of MIF has been reported to lead to reduction
or loss of MIF catalytic activity (29, 31). In our hands, we
consistently observed that deletion of the C-terminal region
abolishes MIF tautomerase activity. Considering the active
site of MIF and its location relative to the C-terminus of
each monomer (Figure 1C), there are two possible explana-
tions for the loss of activity upon deleting the last 5-10
C-terminal residues of MIF: (i) dissociation of the trimer or
(ii) or changes in tertiary structures and dynamics, in
particular involving the active site, induced by disruption of
the intersubunit -sheet formed by C-terminal strand 6 of
one monomer and 5 strand of the neighboring monomer.
To test these possibilities, we determined the effect of the
C-terminal deletions on the oligomeric state (by sedimenta-
tion velocity analytical ultracentrifugation, gel filtration, light
scattering and native gel electrophoresis), secondary structure
(far UV/CD), and tertiary structure (fluorescence spectros-
copy and NMR) of wt and both mutants. Sedimentation
velocity analytical ultracentrifugation studies demonstrate that
both mutants sediment predominantly as a single species with
sedimentation coefficient and molecular weight values
(Figure 4B) corresponding to that of the trimer, suggesting
that C-terminal deletions do not significantly affect the
quaternary structure (trimer) of MIF. It is noteworthy that
the C-terminal deletion mutants exhibited increased propen-
sity to form irreversible aggregates with time and higher
monomer contents relative to wt MIF, indicating that
disruption of this region may alter the kinetic stability of
the trimer.
RemoVal of the C-Terminal Strands 6 and/or 7 Alters
the Conformational Properties of the MIF Trimer. Despite
the similarity in sedimentation properties among the wt and
C-terminal deletion mutants, the gel filtration profiles and
electrophoretic mobility in native gels of both mutants were
distinct from those of the wt protein. Wt huMIF elutes as
two main overlapping peaks, whereas both mutant elute
as a single peak (Figure 4D). In native gels, wt MIF runs as
two distinct bands, whereas both C-terminal deletion mutants
run as a single band with electrophoretic mobility similar to
the fast moving band of wt huMIF. Light scattering measure-
ments proved that both peaks corresponding to wt huMIF
as well as C-terminal deleted mutants correspond to the
trimeric state of MIF. Together these data suggest that MIF
trimer exists as a mixture of at least two different, but closely
related, conformational states and that the tertiary structure
of the trimer is altered by conformational changes and/or
disruption of the C-terminal region 105-114.
To better understand the structural basis underlying the
changes in gel filtration and electrophoretic mobility as well
as the loss of catalytic activity upon deletion of the
C-terminal -strands (6 and/or 7), we probed the secondary
and tertiary structure of wt and C-terminal deletion mutants
by far-UV/CD, NMR spectroscopy and molecular dynamics.
Although the CD spectra of the mutants are very similar to
that of the wt and consistent with the loss of -sheet structure
upon deletion of the -strands 6 and/or 7, the NMR spectra
unambiguously show that deletion of the five C-terminal
residues strongly destabilizes almost the entire protein, such
that the backbone is strongly involved into chemical ex-
change. These findings are consistent with the decreased
thermodynamic stability of both mutants relative to the wt
protein (Figure 3). Deletion of the 6 and 7 was expected
to result in the loss of hydrogen bonding and salt-bridge
intersubunit interaction and lead to increased destabilization
relative to the ∆C5 mutant, which was designed to disrupt
the salt-bridge interaction while maintaining the intersubunit
interactions between 6 from one monomer and 5 of the
neighboring monomer. Although both mutants exhibited
decreased thermodynamic stability relative to wt huMIF,
truncation of the C-terminal -hairpin has less effect on the
stability of MIF than the deletion of the -strand 7. ∆C10
huMIF1-104 was more stable than ∆C5 huMIF1-109 to thermal
and GdnHCl induced denaturation and exhibited reduced
binding to ANS, suggesting that changes in tertiary structure
induced by removal of the C-terminal -hairpin (6 and 7)
induces more stable interactions within the protein that
compensate for some of the trimer stabilizing interactions
involving the -strands 6 and 7 lost. Furthermore, our
molecular dynamics simulations demonstrate that the salt
bridge at the carboxy-terminus still forms in both mutants
and may constitute a major structural element in modulating
the oligomerization and stability of MIF. However, distance
distribution of the salt bridge at the carboxy terminus is
marginally higher in ∆C10 huMIF1-104 compared to ∆C5
huMIF1-109 (Figure 10) consistent with the experimental data
demonstrating that ∆C5 huMIF1-109 is less stable than ∆C10
huMIF1-104.
NMR chemical shifts are highly sensitive to the chemical
environment and provide excellent probes for the secondary
and tertiary structure of proteins. The large spread of signals
observed in the proton dimension of the NMR spectra of
∆C5- and ∆C10-truncated MIF demonstrated that the dele-
tion mutants retain a globular three-dimensional fold (Figures
7A, 8A). Proton amide chemical shifts downfield of 8.5 ppm
report on the presence of -strands in ∆C5- and ∆C10-
truncated MIF in agreement with CD spectroscopy. On the
other hand, the dramatic changes in the NMR spectra indicate
that deletion of five or ten residues at the C-terminus not
only affects the local environment, but influences all the
structure of MIF. The line width of NMR signals depends
on the molecular weight of the protein as well as the internal
flexibility of residues. Increasing molecular weight causes
line broadening whereas higher internal mobility leads to
narrower NMR signals. On the other hand, chemical
exchange between different conformations that is intermedi-
ate on the NMR time scale leads to broadening of NMR
signals. Analytical ultracentrifugation showed that ∆C5-
truncated MIF retains the trimeric arrangement seen for the
wt protein in various crystal structures. Thus, the increased
line widths observed for the truncation mutants of MIF are
most likely not due to a higher-order oligomeric state of the
Role of the C-Terminus in MIF Stability and Activity Biochemistry, Vol. 47, No. 40, 2008 10753
protein. At the same time, unspecific aggregation appears
not to play a major role as 6-fold reduction of the concentra-
tion did not alter the position and line width of signals
significantly. The increased line width, as well as the
disappearance of 30% of signals and the presence of two
conformations for Gly51, rather suggests that truncation of
the C-terminus leads to strong chemical exchange within the
MIF molecule. The conformational exchange might take
place within the subunits but also in the intermolecular
interfaces of the MIF homotrimer. Importantly, it was
previously shown that protein motions necessary for catalysis
are an intrinsic property of the enzyme and may even limit
the overall turnover rate (51). Therefore the impairment of
catalytic activity of MIF might also be a direct consequence
of the observed changes in the intrinsic dynamics of truncated
MIF.
Conformational Flexibility of the C-Terminal Region May
Be Responsible for the Catalytic and Biological ActiVities
of MIF. Our results suggest that differences in tertiary
structure and intrinsic protein dynamics, rather than oligo-
meric state, may underlie the loss of activity upon deletion
of the C-terminal residues 105-114. Previously it was shown
that Pro1 interacts with p-hydroxyphenylpyruvate. NMR
spectroscopy, however, showed that binding of p-hydrox-
yphenylpyruvate to MIF affects not only the N-terminus of
MIF but a much larger set of residues including several
residues at the C-terminus (Asn102, Gly107, Trp108, Phe113
and Ala 114) (Figure 1C). These residues cluster around Pro1
but arise partially from different subunits. Interestingly,
Ala38 and Ile64 disappeared upon addition of p-hydroxy-
phenylpyruvate and they are also no longer visible upon
truncation of MIF at Asn109 (52).
To better understand whether the loss of catalytic activity
and decreased thermodynamic stability upon deletion of the
C-terminal residues 105-114 is due to the truncation or
simply disruption of the C-terminal -hairpin, P107 was
generated. Far UV/CD, AUC and biochemical studies reveal
that insertion of proline at this site disrupts the C-terminal 
hairpin and results in a loss of catalytic activity (Figure 6).
Similar to the C-terminal deletion mutants, the P107 variant
was enzymatically inactive, exhibited decreased thermody-
namic stability and sedimented predominantly as a single
species corresponding to the trimer. These findings are
consistent with our hypothesis that the conformational
flexibility of the C-terminal region, which could also be
induced through changes in solution conditions or interac-
tions between MIF and its partners, may act as a molecular
switch that regulates the equilibrium between the different
trimeric states of MIF, most likely by altering the tertiary
structure and/or stability of the trimer.
Although we did not investigate the effect of the C-
terminal deletions in regulating the biological activities of
MIF, previous studies have shown that similar truncation
abolishes the MIF’s macrophage activating properties (29, 31).
If, indeed, truncation of the C-terminus or disruption of its
structure leads to reduction or blocking of MIF biological
activity, this would suggest that such disrupted activity is
linked to the catalytic activity of MIF, which can be verified
by mutating the N-terminal proline. An alternative explana-
tion would be that the disrupted biological activity is linked
to a specific conformation of the MIF trimer which is
accessible to the wt protein but not to the mutants. The fact
that at least one of the trimers formed by the wt, albeit a
minor species, exhibits similar properties as the C-terminal
deletion mutants suggests that this activity may be regulated
by factors that influence the conformational flexibility and
stability of the trimer. Although our results suggest that the
C-terminus of MIF is not involved in receptor (CD74)
binding, further studies are required to determine whether
these mutations affect huMIF signal transduction necessary
for intracellular MIF activity. Given its conformational
flexibility and accessibility, it is tempting to speculate that
the C-terminus of MIF may play a critical role in modulating
specific protein-protein and protein-small molecule interac-
tions or in regulating MIF’s interaction with fatty acids and
biological membranes.
CONCLUSION
In this study, we investigated the role of the C-terminal
region in modulating the tertiary structure, thermodynamic
stability, receptor binding and enzymatic activity of MIF.
Two C-terminal deletion and Pro insertion mutants were
generated to probe the effect of the various intersubunit
interactions involving the C-terminal region comprising the
amino acid residues 105-114. Our results suggest that the
carboxy-terminal region is required for stabilizing the tertiary
structure of MIF and maintaining it in an enzymatically active
conformation, but does not play a significant role in
modulating the oligomerization (trimer formation) of MIF.
Although removal of the C-terminal residues 110-114 or
105-114 has no effect on trimer formation and MIF binding
to CD74, it causes significant structural changes in the
structure and intrinsic dynamics in most of the protein
including active site. These changes resulted in loss of
tautomerase activity and suggest a possible role for this
region in regulating the conformational flexibility of MIF
and fine-tuning its catalytic activity. However, further
structure activity studies are required to determine the role
of the C-terminal region of MIF in modulating its various
biological activities in vivo.
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